Paediatric healthcare startup Hoola Health raises $5 million from Peak XV’s Surge, othersThe Bengaluru-headquartered startup, founded in 2024 by Deeksha Senguttuvan, offers paediatric consultations, vaccinations, diagnostics, de...
10 Jun, 2026, 02.26 PM IST
AI not a threat, but opportunity for IT services: TCS chairman N ChandrasekaranAddressing the concerns that AI could reduce demand for traditional IT services, Chandrasekaran said the market has misunderstood the relat...
09 Jun, 2026, 09.07 PM IST
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
09 Jun, 2026, 08.48 PM IST
AI coding startup Cursor, courted by SpaceX, picks London as European hubElon Musk's SpaceX, which is readying for a closely watched IPO this week, said in April it had secured an option to either acquire code-...
09 Jun, 2026, 10.35 AM IST
Wealth firm Nexedge Capital looking to close a $25 million funding round to be led by MiraeNexedge Capital, a wealth management firm for ultra-high-net-worth individuals, is nearing a $25 million funding round. South Korean firm M...
09 Jun, 2026, 06.00 AM IST
Sachin Bansal’s Navi in talks to raise $250-300 million from Prosus, Accel USSachin Bansal's Navi Technologies is in talks to raise $250-300 million at a $1.8-2 billion valuation, potentially from Prosus and Accel Gr...
09 Jun, 2026, 06.00 AM IST
Lenskart shares in focus after Viridian completes stake transfer from Copthall MauritiusHong Kong-based Viridian Asia Opportunities Master Fund acquired an 18.96 lakh share stake in Lenskart Solutions for Rs 96 crore. This foll...
08 Jun, 2026, 08.15 PM IST
HFCL shares slip 10% in two sessions after sharp 165% rally in 2026HFCL shares have corrected about 10% in two sessions after a sharp 165% rally in 2026, driven largely by profit booking. Despite strong fun...
08 Jun, 2026, 10.49 AM IST
Buy, Sell or Hold: Morgan Stanley maintains underweight on Wipro; HDFC Securities upgrades Stylam IndustriesBrokerages remain selective on Indian equities, with Morgan Stanley maintaining an underweight stance on Wipro due to growth concerns. HDFC...
08 Jun, 2026, 09.34 AM IST
Two Adani Group stocks in focus as GQG sells stake in Rs 5,750 crore deal; SBI MF lone buyerAdani Enterprises and Adani Energy Solutions will be in focus after GQG Partners sold stakes worth about Rs 5,750 crore via block deals, wi...
08 Jun, 2026, 09.14 AM IST
Room for less: Could short-stay hotels be the next big thing in hospitality?Hourly Hotels: This works on a pay-for-use model where guests pay only for the duration they need a room — typically 3-9 hours. The busines...
07 Jun, 2026, 01.55 PM IST
Tata Motors' expansion to go on, Iveco acquisition to help it rank among top 4 global CV makers: N ChandrasekaranTata Motors is gearing up for an ambitious global journey, aiming to redefine its role in emerging commercial vehicle markets, chairman Cha...
05 Jun, 2026, 05.37 PM IST
Titan Company shares gain 2%. Why JPMorgan, others see up to 28% upside after analyst call?Titan shares are seeing gains as brokerages maintain a positive outlook. The company has outlined ambitious growth plans for the coming yea...
05 Jun, 2026, 01.26 PM IST
UBS downgrades BHEL shares to Neutral from Buy. Check target, key reasonsUBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised ...
04 Jun, 2026, 11.56 AM IST
'Wait out IT, buy pharma and defence'; Ajay Bagga's 3-sector playbook for 2026Ajay Bagga offers a clear strategy for Indian markets. He advises waiting for real AI revenue in IT. Pharma remains a strong investment due...
03 Jun, 2026, 10.48 AM IST
SpaceX plans to set IPO price at $135 per share, targeting $75 billion raise: ReportSpaceX is set to price its IPO at $135 per share, aiming to raise $75 billion and achieve a $1.75 trillion valuation. The company is breaki...
03 Jun, 2026, 09.25 AM IST
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
02 Jun, 2026, 05.48 AM IST